Lupin 2023

generic version of Baraclude

Aurobindo cleared to market Baraclude generic

Aurobindo cleared to market Baraclude generic

DAYTON, N.J. — Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.5 mg and 1 mg) from Bristol-Myers Squibb. Entecavir tablets

Camber rolls out Baraclude generic

Camber rolls out Baraclude generic

PISCATAWAY, N.J. — Camber Pharmaceuticals Inc. has launched entecavir tablets, an antiviral medication. Camber said Friday that its entecavir product is available in 30- and 90-count bottle for the 0.5-mg strength and in 30-count bottles for the 1-mg dosage. The drug is a generic version of Baraclude tablets (entecavir) from Bristol-Myers Squibb Co. The product

PP_1170x120_10-25-21